Artificial Intelligence in Health Fund Files AIHF I at $6.4M

A new dedicated vehicle at the intersection of artificial intelligence and healthcare has emerged: AIHF I, a series of Artificial Intelligence in Health Fund, LP, filed $6.4 million on August 13, 2026, classified as an AI and ML venture capital fund.

The fund name makes the thesis explicit: AI applied to health outcomes, clinical operations, or life sciences data infrastructure. The Series I designation and the $6.4 million first close indicate this is a new fund manager entering the market with a dedicated healthcare AI strategy, not an extension of an established firm. First closes at this size typically reflect a core LP group, often high-net-worth individuals with domain expertise in healthcare or AI, anchoring the fund before a broader LP raise.

Healthcare AI is one of the most active investment themes in venture in 2026. Regulatory guidance from the FDA on AI-assisted diagnostic tools has matured, EHR data availability has expanded through interoperability standards, and a growing body of clinical evidence is making it easier for hospital systems and payers to justify procurement of AI-augmented tools. These conditions are driving both LP demand for dedicated healthcare AI funds and founder opportunity in the sector.

A first-close fund at the $6.4 million mark is typically the most accessible entry point for founders in that sector. The GP is actively building a portfolio and has not yet filled their target company count. Check sizes are small enough to move at seed stage without requiring a large co-investor syndicate. Healthcare AI founders building in diagnostics, clinical workflow automation, or life sciences data infrastructure should track AIHF I as it continues its raise. Find similar healthcare AI investors through the AngelLinx investor directory.

Source: AngelLinx Intelligence